Clinical Research Directory
Browse clinical research sites, groups, and studies.
Combination of Pregabalin and Trigger Point Injection With Ropivacaine in the Treatment of Myofascial Pain Syndrome of the Neck and Upper Back.
Sponsor: National and Kapodistrian University of Athens
Summary
This study compared trigger point injections with ropivacaine alone versus trigger point injections combined with oral pregabalin in adults with chronic myofascial pain of the neck and upper back. Participants were randomly assigned to one of the two treatment groups. Pain intensity, number of trigger points, neuropathic pain symptoms, and health-related quality of life were assessed at baseline and at 1 and 3 months after treatment.
Official title: Combination of Pregabalin and Trigger Point Injection With Ropivacaine in the Treatment of Myofascial Pain Syndrome.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
74
Start Date
2025-03-01
Completion Date
2025-12-20
Last Updated
2026-10-08
Healthy Volunteers
No
Conditions
Interventions
Ropivacaine
Ropivacaine 0.2%, administered as a 2 mL injection into each identified trigger point.
Pregabalin
Pregabalin 50 mg administered orally twice daily.
Locations (1)
Hippocration General Hospital of Athens
Athens, Greece